Skip to main content
. 2020 Jan 23;52:102632. doi: 10.1016/j.ebiom.2020.102632

Fig. 3.

Fig 3

DLL3 expressions in various cancer cell lines.

(a) Examination of DLL3 expression in SCLC cell lines established from Caucasian and Japanese SCLC patients.

(b) Examination of DLL3 expression in the chemoresistant SCLC cell lines, H69/CDDP, H69/VP, SBC3/CDDP, SBC3/ETP, and SBC3 /SN38. CDDP, cisplatin; ETP, etoposide; SCLC, small cell lung cancer; SN38, 7-ethyl-10-hydroxycamptothecin; VP, vePesid.